Cross Country Healthcare buy Benchmark Co.
Start price
22.02.24
/
50%
€15.60
Target price
22.02.25
€19.41
Performance (%)
3.85%
End price
23.02.25
€16.20
Summary
This prediction ended on 23.02.25 with a price of €16.20. With a performance of 3.85%, the BUY prediction by Benchmark_Co_ for Cross Country Healthcare closed with a slight gain. Benchmark_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cross Country Healthcare | 5.970% | 5.970% | -58.721% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by Benchmark_Co_ for this prediction
In the thread Cross Country Healthcare diskutieren
Cross Country Healthcare, Inc. (NASDAQ: CCRN) had its price target lowered by analysts at Benchmark Co. from $24.00 to $21.00. They now have a "buy" rating on the stock.
Ratings data for CCRN provided by MarketBeat
In the thread Trading Cross Country Healthcare
Die von Benchmark_Co_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Benchmark_Co_ for Cross Country Healthcare
Cross Country Healthcare
Start price
Target price
Perf. (%)
€11.30
07.11.24
07.11.24
€16.64
07.11.25
07.11.25
-6.19%
08.11.25
08.11.25
Cross Country Healthcare
Start price
Target price
Perf. (%)
€15.40
02.05.24
02.05.24
€17.74
02.05.25
02.05.25
-23.38%
03.05.25
03.05.25

